Vadim Ivanov Selected Research

Lysine (L-Lysine)

1/2007	Inhibitory effects of a nutrient mixture on human testicular cancer cell line NT 2/DT matrigel invasion and MMP activity.
1/2007	Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture.
11/2006	Inhibition of pulmonary metastasis of melanoma b16fo cells in C57BL/6 mice by a nutrient mixture consisting of ascorbic Acid, lysine, proline, arginine, and green tea extract.
11/2006	Anticancer effect of lysine, proline, arginine, ascorbic acid and green tea extract on human renal adenocarcinoma line 786-0.
10/2006	In vivo and in vitro antitumor effect of a unique nutrient mixture on lung cancer cell line A-549.
4/2006	Inhibition of matrix metalloproteinase-2 secretion and invasion by human ovarian cancer cell line SK-OV-3 with lysine, proline, arginine, ascorbic acid and green tea extract.
4/2006	Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
1/2006	In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058.
1/2006	Effect of ascorbic acid, lysine, proline, and green tea extract on human osteosarcoma cell line MNNG-HOS xenografts in nude mice: evaluation of tumor growth and immunohistochemistry.
1/2006	In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vadim Ivanov Research Topics

Disease

22	Neoplasms (Cancer) 01/2013 - 01/2004
11	Neoplasm Metastasis (Metastasis) 01/2013 - 01/2005
4	Infections 01/2021 - 01/2008
4	Melanoma (Melanoma, Malignant) 01/2013 - 01/2006
3	Lymphoma (Lymphomas) 01/2020 - 11/2014
3	Breast Neoplasms (Breast Cancer) 01/2013 - 01/2005
3	Osteosarcoma (Osteogenic Sarcoma) 01/2006 - 02/2005
2	Multiple Myeloma 10/2019 - 01/2018
2	Atherosclerosis 07/2010 - 05/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2006 - 01/2006
2	Prostatic Neoplasms (Prostate Cancer) 01/2005 - 01/2004
1	COVID-19 02/2022
1	Plasmablastic Lymphoma 04/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Sepsis (Septicemia) 01/2018
1	Frailty 03/2016
1	Heart Failure 03/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Angina Pectoris 01/2016
1	Myocardial Infarction 01/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2014
1	Necrosis 01/2013
1	Hodgkin Disease (Hodgkin's Disease) 07/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2012
1	Virus Diseases (Viral Diseases) 05/2011
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 01/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2010
1	Aortic Dissection 05/2010

Drug/Important Bio-Agent (IBA)

20	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2013 - 01/2004
19	Proline (L-Proline)FDA Link 01/2007 - 01/2004
19	Lysine (L-Lysine)FDA Link 01/2007 - 01/2004
18	TeaIBA 03/2010 - 01/2005
17	Arginine (L-Arginine)FDA Link 01/2007 - 01/2004
17	Matrix Metalloproteinases (MMPs)IBA 01/2007 - 01/2004
12	matrigelIBA 01/2007 - 01/2004
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 01/2005
6	Antineoplastic Agents (Antineoplastics)IBA 01/2007 - 01/2004
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
4	GelatinasesIBA 10/2006 - 01/2005
4	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 04/2006 - 01/2004
4	Therapeutic UsesIBA 04/2006 - 01/2005
4	Fibronectins (Fibronectin)IBA 01/2006 - 01/2005
3	Lenalidomide (CC 5013)FDA Link 10/2019 - 09/2010
3	Rituximab (Mabthera)FDA Link 11/2014 - 09/2010
3	MucinsIBA 01/2006 - 01/2005
3	Methylnitronitrosoguanidine (MNNG)IBA 01/2006 - 02/2005
2	VaccinesIBA 02/2022 - 05/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2019 - 09/2010
2	Peptides (Polypeptides)IBA 06/2018 - 05/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2007
2	nilotinib FDA Link 01/2015 - 01/2011
2	EnzymesIBA 05/2011 - 01/2006
2	Apolipoproteins E (ApoE)IBA 07/2010 - 05/2010
2	Angiotensin IIIBA 07/2010 - 05/2010
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 03/2010 - 01/2005
2	Bovine Serum AlbuminIBA 01/2007 - 04/2006
2	Streptomycin (Streptomycin Sulfate)FDA Link 04/2006 - 10/2005
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 04/2006 - 02/2005
2	Penicillins (Penicillin)FDA Link 04/2006 - 10/2005
1	daratumumabIBA 04/2021
1	Respiratory Syncytial Virus VaccinesIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	blinatumomabIBA 01/2020
1	Bortezomib (Velcade)FDA Link 10/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018
1	Potassium Channel Blockers (Blockers, Potassium Channel)IBA 01/2016
1	Nifedipine (Adalat)FDA LinkGeneric 01/2016
1	PalmitatesIBA 01/2016
1	CalciumIBA 01/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2016
1	SodiumIBA 01/2016
1	Dasatinib (BMS 354825)FDA Link 01/2015
1	HomoharringtonineIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	Capsules (Microcapsules)IBA 01/2013
1	gulonolactoneIBA 01/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013
1	CytokinesIBA 01/2013
1	Oxidoreductases (Dehydrogenase)IBA 01/2013
1	Monoclonal AntibodiesIBA 06/2012
1	Heme (Haem)IBA 05/2011
1	Immunoglobulins (Immunoglobulin)IBA 05/2011
1	QuercetinIBA 03/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2008
1	CaspasesIBA 10/2008
1	Hematoxylin (Haematoxylon)IBA 10/2008

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2018 - 01/2005
4	Therapeutics 10/2019 - 01/2007
2	Transplantation 10/2019 - 07/2012
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Catheters 03/2016
1	Salvage Therapy 07/2012
1	Stem Cell Transplantation 07/2012
1	Intraperitoneal Injections 03/2010